When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
APLT - Applied Therapeutics' AT-007 an orphan drug for Galactosemia
Applied Therapeutics Inc.
The FDA has granted Orphan Drug Designation to Applied Therapeutics' (NASDAQ:APLT) AT-007, a central nervous system penetrant Aldose Reductase inhibitor in the late stages of preclinical development for the treatment of Galactosemia.
More news on: Applied Therapeutics, Inc., Healthcare stocks news,